Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 1.21 -4.74% -0.06
MIRA closed down 9.64 percent on Wednesday, November 20, 2024, on 59 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish -4.74%
Expansion Pivot Sell Setup Bearish Swing Setup -4.74%
200 DMA Support Bullish -4.74%
Wide Bands Range Expansion -4.74%
Down 3 Days in a Row Weakness -4.74%
Oversold Stochastic Weakness -4.74%
NR7 Range Contraction -13.93%
Narrow Range Bar Range Contraction -13.93%
Wide Bands Range Expansion -13.93%
Oversold Stochastic Weakness -13.93%

   Recent Intraday Alerts

Alert Time
Down 5% about 1 hour ago
Down 3% about 1 hour ago
Up 5% about 1 hour ago
Up 3% about 1 hour ago
Fell Below 200 DMA about 1 hour ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid

Is MIRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.01
52 Week Low 0.51
Average Volume 1,698,947
200-Day Moving Average 1.23
50-Day Moving Average 1.34
20-Day Moving Average 1.63
10-Day Moving Average 1.52
Average True Range 0.21
RSI (14) 40.48
ADX 23.78
+DI 19.08
-DI 25.74
Chandelier Exit (Long, 3 ATRs) 1.93
Chandelier Exit (Short, 3 ATRs) 1.67
Upper Bollinger Bands 2.18
Lower Bollinger Band 1.09
Percent B (%b) 0.16
BandWidth 66.61
MACD Line 0.01
MACD Signal Line 0.07
MACD Histogram -0.06
Fundamentals Value
Market Cap 18.7 Million
Num Shares 14.8 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -2.48
Price-to-Sales 0.00
Price-to-Book 1.93
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.69
Resistance 3 (R3) 1.69 1.55 1.62
Resistance 2 (R2) 1.55 1.44 1.55 1.59
Resistance 1 (R1) 1.41 1.38 1.34 1.41 1.57
Pivot Point 1.27 1.27 1.23 1.27 1.27
Support 1 (S1) 1.13 1.16 1.06 1.13 0.96
Support 2 (S2) 0.99 1.10 0.99 0.94
Support 3 (S3) 0.85 0.99 0.92
Support 4 (S4) 0.85